![](/img/cover-not-exists.png)
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
Smith, David C., Chugh, Rashmi, Patnaik, Amita, Papadopoulos, Kyriakos P., Wang, Min, Kapoun, Ann M., Xu, Lu, Dupont, Jakob, Stagg, Robert J., Tolcher, AnthonyLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0714-6
Date:
December, 2018
File:
PDF, 1.50 MB
english, 2018